110 related articles for article (PubMed ID: 17972524)
1. Razoxane and vindesine in advanced soft tissue sarcomas: impact on metastasis, survival and radiation response.
Rhomberg W; Eiter H; Schmid F; Saely C
Anticancer Res; 2007; 27(5B):3609-14. PubMed ID: 17972524
[TBL] [Abstract][Full Text] [Related]
2. Combined vindesine and razoxane shows antimetastatic activity in advanced soft tissue sarcomas.
Rhomberg W; Eiter H; Schmid F; Saely CH
Clin Exp Metastasis; 2008; 25(1):75-80. PubMed ID: 17932774
[TBL] [Abstract][Full Text] [Related]
3. Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation.
Rhomberg W; Wink A; Pokrajac B; Eiter H; Hackl A; Pakisch B; Ginestet A; Lukas P; Pötter R
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):187-91. PubMed ID: 19004568
[TBL] [Abstract][Full Text] [Related]
4. Treatment options for malignant hemangioendotheliomas of the thyroid.
Rhomberg W; Boehler F; Eiter H; Fritzsche H; Breitfellner G
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):401-5. PubMed ID: 15380572
[TBL] [Abstract][Full Text] [Related]
5. Irradiation with and without razoxane in the treatment of incompletely resected or inoperable recurrent rectal cancer. Results of a small randomized multicenter study.
Rhomberg W; Hammer J; Sedlmayer F; Eiter H; Seewald D; Schneider B
Strahlenther Onkol; 2007 Jul; 183(7):380-4. PubMed ID: 17609871
[TBL] [Abstract][Full Text] [Related]
6. Concomitant chemo-radiotherapy in the treatment of locally advanced and/or metastatic soft tissue sarcomas: experience of the National Cancer Institute of Genoa.
Toma S; Canavese G; Grimaldi A; Ravera G; Ugolini D; Percivale P; Badellino F
Oncol Rep; 2003; 10(3):641-7. PubMed ID: 12684637
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study.
Rhomberg W; Hassenstein EO; Gefeller D
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1077-84. PubMed ID: 8985029
[TBL] [Abstract][Full Text] [Related]
8. Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome.
Takeuchi A; Tsuchiya H; Yamamoto N; Hayashi K; Yamauchi K; Kawahara M; Miyamoto K; Tomita K
Anticancer Res; 2007; 27(5B):3489-95. PubMed ID: 17972506
[TBL] [Abstract][Full Text] [Related]
9. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy and razoxane in advanced bile duct carcinomas.
Rhomberg W; Stephan H; Böhler F; Erhart K; Eiter H
Anticancer Res; 2005; 25(5):3613-8. PubMed ID: 16101189
[TBL] [Abstract][Full Text] [Related]
11. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
[TBL] [Abstract][Full Text] [Related]
12. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
[TBL] [Abstract][Full Text] [Related]
13. Combined radiotherapy and razoxane in the treatment of chondrosarcomas and chordomas.
Rhomberg W; Eiter H; Böhler F; Dertinger S
Anticancer Res; 2006; 26(3B):2407-11. PubMed ID: 16821624
[TBL] [Abstract][Full Text] [Related]
14. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group.
Eigentler TK; Radny P; Hauschild A; Gutzmer R; Linse R; Pföhler C; Wagner SN; Schadendorf D; Ellwanger U; Garbe C;
Melanoma Res; 2008 Oct; 18(5):353-8. PubMed ID: 18781134
[TBL] [Abstract][Full Text] [Related]
16. Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients.
Cherix S; Speiser M; Matter M; Raffoul W; Liénard D; Theumann N; Mouhsine E; Mirimanoff RO; Leyvraz S; Lejeune FJ; Leyvraz PF
J Surg Oncol; 2008 Sep; 98(3):148-55. PubMed ID: 18668638
[TBL] [Abstract][Full Text] [Related]
17. Isolated limb infusion for advanced soft tissue sarcoma of the extremity.
Moncrieff MD; Kroon HM; Kam PC; Stalley PD; Scolyer RA; Thompson JF
Ann Surg Oncol; 2008 Oct; 15(10):2749-56. PubMed ID: 18648882
[TBL] [Abstract][Full Text] [Related]
18. Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumors.
Bauer S; Hartmann JT
Crit Rev Oncol Hematol; 2006 Nov; 60(2):112-30. PubMed ID: 16949832
[TBL] [Abstract][Full Text] [Related]
19. Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation.
Muhic A; Hovgaard D; Mørk Petersen M; Daugaard S; Højlund Bech B; Roed H; Kjaer-Kristoffersen F; Aage Engelholm S
Radiother Oncol; 2008 Sep; 88(3):382-7. PubMed ID: 18584905
[TBL] [Abstract][Full Text] [Related]
20. Limb salvage surgery in combination with brachytherapy and external beam radiation for high-grade soft tissue sarcomas.
Beltrami G; Rüdiger HA; Mela MM; Scoccianti G; Livi L; Franchi A; Campanacci DA; Capanna R
Eur J Surg Oncol; 2008 Jul; 34(7):811-6. PubMed ID: 17981427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
